Trademark: 79184853
Word
CHONYLATION
Status
Dead
Status Code
709
Status Date
Friday, September 8, 2023
Serial Number
79184853
Registration Number
5143900
Registration Date
Tuesday, February 21, 2017
Mark Type
4
Filing Date
Wednesday, October 14, 2015
Published for Opposition
Tuesday, December 6, 2016
Cancellation Date
Friday, September 8, 2023

Trademark Owner History

Classifications
40 Custom manufacture of pharmaceuticals, namely, synthesizing, processing and purification of pharmaceutical preparations; Provision of information and consultancy relating to custom manufacture of pharmaceuticals in the nature of synthesizing, processing and purification of pharmaceutical preparations; Custom manufacture of glycosylated pharmaceutical preparations, namely, synthesizing, processing and purification of glycosylated pharmaceutical preparations; Provision of information and consultancy relating to custom manufacture of glycosylated pharmaceuticals, in the nature of synthesizing, processing and purification of glycosylated pharmaceutical preparations
42 Scientific and technological services, namely, testing, inspection, and scientific research in the field of pharmaceutical preparations; Medical and pharmaceutical research in the field of pharmaceutical preparations; Provision of information and consultancy relating to testing, inspection or medical and pharmaceutical research of pharmaceutical preparations; Custom developments of pharmaceutical preparations; Provision of information and consultancy relating to custom development of pharmaceutical preparations; Testing, inspection or medical and pharmaceutical research in the fields of glycosylated pharmaceutical preparations, chemistry, biology, and pharmaceuticals; Provision of information and consultancy relating to testing, inspection or medical and pharmaceutical research in the fields of glycosylated pharmaceutical preparations, chemistry, biology, and pharmaceuticals; Conducting clinical trials for others for pharmaceutical preparations; Provision of information and consultancy relating to conducting clinical trials for others for pharmaceutical preparations; Research and development in the field of biochemistry; Provision of information and consultancy relating to research and development in the field of biochemistry

Trademark Events
Mar 19, 2016
Assigned To Examiner
Mar 17, 2016
Sn Assigned For Sect 66a Appl From Ib
Mar 18, 2016
New Application Office Supplied Data Entered
Mar 18, 2016
Limitation From Original Application Entered
Mar 22, 2016
Application Filing Receipt Mailed
Mar 23, 2016
Non-Final Action Written
Mar 24, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Mar 25, 2016
Refusal Processed By Mpu
Mar 25, 2016
Non-Final Action Mailed - Refusal Sent To Ib
May 14, 2016
Refusal Processed By Ib
Sep 20, 2016
Teas Response To Office Action Received
Oct 5, 2016
Correspondence Received In Law Office
Sep 21, 2016
Teas Response To Office Action Received
Sep 30, 2016
Assigned To Lie
Oct 5, 2016
Teas/Email Correspondence Entered
Nov 16, 2016
Notification Of Notice Of Publication E-Mailed
Dec 6, 2016
Official Gazette Publication Confirmation E-Mailed
Dec 17, 2016
Notification Processed By Ib
Feb 21, 2017
Registered-Principal Register
May 21, 2017
Final Disposition Notice Created, To Be Sent To Ib
Oct 28, 2016
Approved For Pub - Principal Register
Nov 3, 2016
Law Office Publication Review Completed
Nov 30, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 30, 2016
Notification Of Possible Opposition Sent To Ib
Dec 6, 2016
Published For Opposition
Sep 8, 2023
Cancelled Section 71
Jul 28, 2017
Generic Madrid Transaction Created
Jul 29, 2017
Generic Madrid Transaction Sent To Ib
Oct 20, 2017
Final Decision Transaction Processed By Ib
Feb 21, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 30, 2022
New Representative At Ib Received
May 8, 2024
Total Invalidation Of Reg Ext Protection Created
May 14, 2024
Generic Madrid Transaction Sent To Ib
May 14, 2024
Generic Madrid Transaction Created
Jun 17, 2024
Total Invalidation Processed By The Ib

Trademark Alertz updated from USPTO on 2030-01-24